EDIT vs ICE
Editas Medicine Inc (EDIT) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
EDIT currently screens at market cap $375.2M. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the EDIT and ICE stock pages for the full models.
Not investment advice.